FR2189021A1 - Non-arthrogenic immunological adjuvants - obtained by extraction of lipid-free mycobacterial residues - Google Patents

Non-arthrogenic immunological adjuvants - obtained by extraction of lipid-free mycobacterial residues

Info

Publication number
FR2189021A1
FR2189021A1 FR7222208A FR7222208A FR2189021A1 FR 2189021 A1 FR2189021 A1 FR 2189021A1 FR 7222208 A FR7222208 A FR 7222208A FR 7222208 A FR7222208 A FR 7222208A FR 2189021 A1 FR2189021 A1 FR 2189021A1
Authority
FR
France
Prior art keywords
lipid
residues
opt
extraction
immunological adjuvants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7222208A
Other languages
English (en)
Other versions
FR2189021B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Priority to FR7222208A priority Critical patent/FR2189021A1/fr
Priority to BE132359A priority patent/BE801016A/fr
Priority to NL7308450A priority patent/NL7308450A/xx
Priority to DE2331144A priority patent/DE2331144A1/de
Priority to CH1284476A priority patent/CH592452A5/xx
Priority to HU73AA740A priority patent/HU172600B/hu
Priority to US05/371,658 priority patent/US3956481A/en
Priority to JP48069140A priority patent/JPS4954590A/ja
Priority to GB2899273A priority patent/GB1439847A/en
Priority to IL42545A priority patent/IL42545A/en
Priority to CA174,439A priority patent/CA1006836A/en
Priority to CH890773A priority patent/CH602117A5/xx
Publication of FR2189021A1 publication Critical patent/FR2189021A1/fr
Priority to DK688474A priority patent/DK688474A/da
Application granted granted Critical
Publication of FR2189021B1 publication Critical patent/FR2189021B1/fr
Priority to US05/610,477 priority patent/US4001395A/en
Priority to SE7604289A priority patent/SE7604289L/xx
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
FR7222208A 1972-06-20 1972-06-20 Non-arthrogenic immunological adjuvants - obtained by extraction of lipid-free mycobacterial residues Granted FR2189021A1 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
FR7222208A FR2189021A1 (en) 1972-06-20 1972-06-20 Non-arthrogenic immunological adjuvants - obtained by extraction of lipid-free mycobacterial residues
BE132359A BE801016A (fr) 1972-06-20 1973-06-15 Extraits hydrosolubles de mycobacteries
NL7308450A NL7308450A (fr) 1972-06-20 1973-06-18
CA174,439A CA1006836A (en) 1972-06-20 1973-06-19 Hydrosoluble extracts of mycobacteria, their preparation and use
HU73AA740A HU172600B (en) 1972-06-20 1973-06-19 Process for producing water-soluble extrakts from mycobacteria and utilizing them as immunological adjuvants
US05/371,658 US3956481A (en) 1972-06-20 1973-06-19 Hydrosoluble extracts of mycobacteria, their preparation and use
JP48069140A JPS4954590A (fr) 1972-06-20 1973-06-19
GB2899273A GB1439847A (en) 1972-06-20 1973-06-19 Bacterial extracts
DE2331144A DE2331144A1 (de) 1972-06-20 1973-06-19 Wasserloesliche extrakte von mycobacterien
CH1284476A CH592452A5 (fr) 1972-06-20 1973-06-19
CH890773A CH602117A5 (fr) 1972-06-20 1973-06-19
IL42545A IL42545A (en) 1972-06-20 1973-06-19 Water-soluble extracts of mycobacteria their preparation and pharmaceutical compositions containing them
DK688474A DK688474A (fr) 1972-06-20 1974-12-30
US05/610,477 US4001395A (en) 1972-06-20 1975-09-04 Hydrosoluble extracts of mycobacteria
SE7604289A SE7604289L (sv) 1972-06-20 1976-04-12 Vattenlosliga extrat av mykobakterier, deras framstellning och anvendning

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7222208A FR2189021A1 (en) 1972-06-20 1972-06-20 Non-arthrogenic immunological adjuvants - obtained by extraction of lipid-free mycobacterial residues

Publications (2)

Publication Number Publication Date
FR2189021A1 true FR2189021A1 (en) 1974-01-25
FR2189021B1 FR2189021B1 (fr) 1975-06-20

Family

ID=9100480

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7222208A Granted FR2189021A1 (en) 1972-06-20 1972-06-20 Non-arthrogenic immunological adjuvants - obtained by extraction of lipid-free mycobacterial residues

Country Status (2)

Country Link
BE (1) BE801016A (fr)
FR (1) FR2189021A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2419071A1 (fr) * 1978-03-10 1979-10-05 Mitsui Toatsu Chemicals Extrait cellulaire bacterien, procede de preparation, preparation antitumorale et preparation adjuvante le contenant
FR2529462A1 (fr) * 1982-06-30 1984-01-06 Ribi Immunochem Research Inc Composition pharmaceutique comprenant un extrait de micro-organisme soluble dans la pyridine, un dimycolate de trehalose et un derive de glycolipides endotoxiques
FR2536280A1 (fr) * 1982-06-30 1984-05-25 Ribi Immunochem Research Inc Composition pharmaceutique et procede pour le traitement de tumeurs

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, VOLUME 76, REFERENCE 137850R 1972 CITE OSAKA DAIGAKU SHIGAKY ZASSHI 1970, 15 1 , 111-40.) *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2419071A1 (fr) * 1978-03-10 1979-10-05 Mitsui Toatsu Chemicals Extrait cellulaire bacterien, procede de preparation, preparation antitumorale et preparation adjuvante le contenant
FR2529462A1 (fr) * 1982-06-30 1984-01-06 Ribi Immunochem Research Inc Composition pharmaceutique comprenant un extrait de micro-organisme soluble dans la pyridine, un dimycolate de trehalose et un derive de glycolipides endotoxiques
FR2536280A1 (fr) * 1982-06-30 1984-05-25 Ribi Immunochem Research Inc Composition pharmaceutique et procede pour le traitement de tumeurs

Also Published As

Publication number Publication date
FR2189021B1 (fr) 1975-06-20
BE801016A (fr) 1973-12-17

Similar Documents

Publication Publication Date Title
AT337130B (de) Verfahren zur abtrennung bzw. isolierung von sauren aus wasserigen losungen, insbesondere zur gewinnung von zitronensaure aus zitronensaurefermentationsbruhe
GB1439847A (en) Bacterial extracts
ES416573A1 (es) Metodo de extraer mucopolisacaridos de tejidos conjuntivos de animales.
BE785518A (fr) Methode d'extraction des substances proteiniques et lipidiques du serumet du plasma sanguins
CA1010710A (en) Protein and method of extracting same from soybeans
HUT35521A (en) Process for preparing a pharmaceutical composition containing a purified, detixicated endotoxine and a pyridine soluble extract of a microorganism
AR246166A1 (es) Procedimiento para extraer selectivamente las metalo-proteinas del lactoserum y lactoferrina y lactoperoxidasa asi obtenidas.
FR2189021A1 (en) Non-arthrogenic immunological adjuvants - obtained by extraction of lipid-free mycobacterial residues
ES432696A1 (es) Procedimiento de preparacion de vacunas.
FR2227862A1 (en) Non-arthrogenic immunological adjuvants - obtained by extraction of lipid-free mycobacterial residues
DE3850257D1 (de) Verfahren zur herstellung tierärztlicher acellularer impfstoffe gegen gramnegative momenterische pathogene bazillen.
NL7611691A (nl) Werkwijze voor de bereiding van stabiele dispersies van colofonium in water.
EP0090660A3 (fr) Vaccin anti-gonococcique
FR2517967B1 (fr)
DK421486A (da) Polydisperse native pseudomonas-flagella(h)-antigener (fag) og fremgangsmaade til deres udvinding
DK129514B (da) Fremgangsmåde til fremstilling af eventuelt 21-substituerede og/eller eventuelt 1(2)-umættede 6,6,9α-trifluor-11β,16α-17α-trihydroxy-4-pregnen-3,20-dion-16,17-ketaler.
CA1009972A (en) Water-soluble immunological adjuvants in particular for vaccines, obtained from mycobacteria and related microorganisms and process for their extraction
NL184614C (nl) Werkwijze voor de bereiding van propionzuur en/of propionzuuranhydride.
FR2055537A5 (en) Separation of pure proteins
NL175625C (nl) Werkwijze voor het winnen van proteinen met een inhiberende werking op de weefselimmuniteit alsmede werkwijze ter bereiding van een immuniteit onderdrukkend preparaat.
AU5706973A (en) Water-soluble immunological adjuvants in particular for vaccines, obtained from mycobacteria and related microorganisms and process for their extraction
FR2189020A1 (en) Water-soluble lipid-free mycobacterial fraction - immuno stimulant and anti tumour agent prepn. from BCG or canetti strains
FR2091427A5 (en) Nutrient media for microorganisms - by extraction of fresh water alga
FR2196152A1 (en) Extract of marsh-mallow root prepn - for use in therapy or in cosmetics
DK133952B (da) Fremgangsmåde til udvinding og rensning af enzymer fra mikroorganismer.